BMY's ulcerative colitis drug fails clinical trial
Post# of 72440
(Total Views: 588)
Posted On: 10/07/2021 11:49:00 AM
BMY's ulcerative colitis drug fails clinical trials. If only we knew of a company that had an anti-inflammatory, antibiotic drug that might help diseases of the gut.....
Quote:
Bristol Myers Squibb’s deucravacitinib, seeking to become the first TYK2 drug approved, flopped a key Phase II test in ulcerative colitis, failing to spur clinical remission at three months and missing key secondary endpoints at an interim check-in, the drug giant admitted Thursday.
https://endpts.com/bristol-myers-tyk2-drug-bo...g-on-deck/
(8)
(2)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼